Fig. 5From: Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulationsValidation by Fischer’s randomization method. Comparison of total cost of Hypo1 with the randomly generated 19 scrambles when 95% confidence level was selectedBack to article page